ATF6 modulates cancer cell dormancy via the activation of Ras homolog enriched in brain (RHEB) and mTOR, in which ATF6 not only plays a role as a key survival factor for quiescent squamous carcinoma cells, but is also pivotal for the adaptation of dormant cells to chemotherapy [153]. The gene discussed is MTOR; the disease is cancer.